MedPath

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

Not Applicable
Recruiting
Conditions
Cancer
Registration Number
NCT05415007
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.

Detailed Description

PRIMARY OBJECTIVE(S)- To examine the feasibility and accessibility of a brief intervention for caregivers of youth with newly-diagnosed cancer as a preliminary, data-generating step toward applying for a larger NCI R34 grant evaluating the efficacy of the program in a randomized controlled trial.

SECONDARY OBJECTIVE(S)- We hope to learn whether a psycho-educational, psychotherapeutic intervention offered in a virtual setting to caregivers of children diagnosed with cancer is feasible, is acceptable, and can prevent, minimize, or improve symptoms of psychological distress (including symptoms of anxiety, depression, and post-traumatic stress disorder). We also hope to further our understanding of family stress and expand the idea for a need of mental health services in pediatric oncology. We aim to further understand intervention strategies for domains of family stress, reducing levels of caregiver anxiety, and promoting resilience for caregivers. This is important because these symptoms can affect the quality of life of caregivers and affect their ability to adhere to their children's treatments.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Parents

Inclusion

  • Child (0-17yrs) with recent (<12 mo) cancer diagnosis
  • Fluent in English
  • Consent to research

Exclusion:

  • Lack of proficiency in written and spoken English
  • Parent is under age 18
  • Active Suicidal Ideation
  • Child with cancer does not provide assent

Inclusion and Exclusion Criteria: Children

Inclusion:

  • Recent (<12 mo) cancer diagnosis in child
  • 8-17 Years old
  • Provides assent to participate in the study

Exclusion:

  • Cannot read English
  • Parent is not enrolled in the study

Anyone who is not a caregiver of children who have been diagnosed with cancer within the past 12 months will be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of caregivers who enroll in the GOLD program1 month

Measurement will be based on the percentage of caregivers who provide consent, and are retained in the program through 1-month follow-up.

Secondary Outcome Measures
NameTimeMethod
Acceptability of the GOLD Program for caregivers1 month

Acceptability will be measure by the percentage of caregivers who provide complete data, and who are retained through 1-month follow-up

Trial Locations

Locations (1)

Stanford Cancer Institute

🇺🇸

San Francisco, California, United States

Stanford Cancer Institute
🇺🇸San Francisco, California, United States
Victoria E. Cosgrove, PhD
Contact
650-995-6848
veileen@stanford.edu
Sheri Spunt, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.